DAVID MOTT

Profile

First Name

: DAVID

Middle Name

:

Last Name

: MOTT

Related Companies
Titles
Company Name
Related People
DIRECTOR
3-V BIOSCIENCES, INC.
JOHN CURNUTTE, XUFANG DUAN, JASON FULLER, ROBERT GARLAND, ARI HELENIUS, REKHA HEMRAJANI, DENNIS HOM, GEORGE KEMBLE, RICK KLAUSNER, MERDAD PARSEY, GORDON RINGOLD, RICHARD RODGERS, BETH SEIDENBERG, JINZI JASON WU, JAMES YOUNG
DIRECTOR
TESARO, INC.
LAWRENCE M. ALLEVA, JAMES O. ARMITAGE, GRANT C. BOGLE, EARL M. COLLIER, JR., JOSEPH L. FARMER, JEFFREY H. HANKE, MARY LYNNE HEDLEY, MARY LYNNE HEDLEY, MARTIN H. HUBER, DAVID M. MOTT, LEON O. MOULDER JR., LEON O. MOULDER, JR., GARRY A. NICHOLSON, ARNOLD ORONSKY, ARNOLD L. ORONSKY, KAVITA PATEL, TIMOTHY R. PEARSON, RICHARD J. RODGERS, BETH SEIDENBERG, PAUL WALKER
DIRECTOR
ARDELYX, INC.
ROBERT BAZEMORE, WILLIAM BERTRAND, JR., JEREMY CALDWELL, DOMINIQUE CHARMOT, DAVID COLLIER, JEAN FRECHET, ELIZABETH GRAMMER, JEFF JACOBS, ANNALISA JENKINS, MARK KAUFMANN, PAUL KORNER, MICHAEL RAAB, GORDON RINGOLD, RICHARD RODGERS, DAVID ROSENBAUM, PETER SCHULTZ, PETER G. SCHULTZ
DIRECTOR
ZYNGENIA, INC.
JOSEPH AMPREY, CARLOS BARBAS, CARLOS F. BARBAS, III, ROBERT GARLAND, DAVID HILBERT, PETER KIENER, PETER A. KIENER, DANIEL MENICHELLA, SCOTT MOTT, DAVID PARKINSON
DIRECTOR
OMTHERA PHARMACEUTICALS, INC.
DOUGLAS CARR, MICHAEL DAVIDSON, GEORGE HORNER, BERNARDUS MACHIELSE, CHRISTIAN SCHADE, GRAZIANO SEGHEZZI, GERALD WISLER
EXECUTIVE OFFICER, DIRECTOR
MERSANA THERAPEUTICS INC
NICHOLAS G. BACOPOULOS, NICHOLAS G. BACOPOULOUS, THOMAS BECK, DONALD BERGSTROM, BURKHARD BLANK, C. CLARKE BOYD, C. BOYD CLARKE, WAYNE FOSTER, KAREN HONG, EVA JACK, ELAINE JONES, MICHAEL J. KAUFMAN, PETER LEONE, TIMOTHY LOWINGER, TIMOTHY B. LOWINGER, MICHAEL METZGER, SARA NAYEEM, JULIE A. OLSON, PETER PARK, ANNA PROTOPAPAS, JOYCE TSANG, MARTIN VOGELBAUM
DIRECTOR
CYDAN, LLC
CHRISTOPH M. ADAMS, CRISTINA CSIMMA, BARBARA DALTON, DEBORAH GERAGHTY, JAMES MCARTHUR, SARA NAYEEM
DIRECTOR
EDIMER PHARMACEUTICALS, INC.
WILLIAM ALISKI, MITCHELL BLOOM, WENDY DIXON, NEIL KIRBY, CARY PFEFFER
DIRECTOR
PROSENSA HOLDING N.V.
GILES CAMPION, LUC DOCHEZ, DAAN ELLENS, GEORGES GEMAYEL, PETER GOODFELLOW, ANNALISA JENKINS, MARTIJN KLEIJWEGT, BERNDT MODIG, HANS SCHIKAN, MICHAEL WYZGA
DIRECTOR
ADAPTIMMUNE LTD
ALI BEHBAHANI, DR. JONATHAN KNOWLES, IAN LAING, JAMES NOBLE, ELLIOTT SIGAL, PETER THOMPSON
EXECUTIVE OFFICER, DIRECTOR
MERSANA THERAPEUTICS, INC.
NICHOLAS G. BACOPOULOS, NICHOLAS G. BACOPOULOUS, THOMAS BECK, DONALD BERGSTROM, BURKHARD BLANK, C. CLARKE BOYD, C. BOYD CLARKE, WAYNE FOSTER, KAREN HONG, EVA JACK, ELAINE JONES, MICHAEL J. KAUFMAN, PETER LEONE, TIMOTHY LOWINGER, TIMOTHY B. LOWINGER, MICHAEL METZGER, SARA NAYEEM, JULIE A. OLSON, PETER PARK, ANNA PROTOPAPAS, JOYCE TSANG, MARTIN VOGELBAUM
DIRECTOR
XTUIT PHARMACEUTICALS, INC.
ALAN CRANE, EDWARD FREEDMAN, RAKESH JAIN, ROBERT LANGER, GARRY NICHOLSON
DIRECTOR
IMARA INC.
CHRISTOPH M. ADAMS, METTE KIRSTINE AGGER, RAHUL BALLAL, JAKE BAUER, DAVID BONITA, MARK CHIN, HELEN COLLINS, BARBARA DALTON, MIKA DERYNCK, CARL GOLDFISCHER, RISHI GUPTA, RICHARD HEYMAN, BENJAMIN HOHL, ROBERT HOPFNER, SAMUEL KINTZ, JOSEPH P. LYSSIKATOS, JAMES G. MCARTHUR, SARA NAYEEM, ANISH PATEL, ANDREW PHILLIPS
DIRECTOR
COMPLEXA INC.
BARBARA DALTON, PETER GREBOW, KENJI HARADA, HIRONORI HOZOJI, DIANE JORKASKY, BERNARDUS N. MACHIELSE, CARTER MEYER, I. WISTAR MORRIS, SARA M. NAYEEM, GILLES M. NOBECOURT, FEDERICA O-BRIEN, FREDERICA O-BRIEN, H. JOSEPH REISER, HAROLD SAFFERSTEIN, FRANCISCO D. SALVA, JOSHUA M. TARNOFF, MIWA TOYODA
DIRECTOR
CYDAN II, INC.
CHRISTOPH M. ADAMS, SANDIP AGARWALA, METTE KIRSTINE AGGER, BARBARA DALTON, JAMES MCARTHUR, SARA NAYEEM
DIRECTOR
TIBURIO THERAPEUTICS INC.
CHRISTOPH M. ADAMS, SANDIP AGARWALA, METTE KIRSTINE AGGER, ABRAHAM N. CEESAY, JAMES G. MCARTHUR, SARA NAYEEM
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-04-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-08 
2019-03-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-15 
2019-02-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-12 
2019-01-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-20 
2017-10-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-28 
2017-07-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-14 
2016-09-02
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-20 
2016-08-01
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-07-18 
2016-07-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-06-17 
2016-06-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-06-15 
2016-04-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-13 
2016-03-01
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-20 
2015-06-22
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-06-05 
2015-06-11
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-20 
2015-03-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-22 
2015-03-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-20 
2014-12-08
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Debt 
2014-11-26 
2014-10-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-23 
2014-04-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-09-27 
2013-10-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-09-27 
2013-10-02
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-28 
2013-08-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-23 
2013-06-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-14 
2013-04-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-28 
2013-02-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2013-02-15 
2012-12-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-29 
2012-09-06
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2012-08-24 
2012-08-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-27 
2012-01-06
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-28 
2011-12-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-29 
2011-07-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-06-23 
2011-06-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-06-06 
2010-12-23
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-10 
2010-12-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-11-16 
2010-05-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-10 
2009-07-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-07